Back to LGND overview

LGND Ligand Pharmaceuticals PE ratio, current and historical analysis

As of Jun 14, 2024, the Ligand Pharmaceuticals stock's PE ratio is 14.69. This results from the current EPS of $5.45 and stock price of $80.06. The P/E ratio has a decrease of 60% from the past four quarters average of 36.4.

LGND PE ratio history

How has LGND's PE ratio performed in the past

The PE ratio of Ligand Pharmaceuticals has averaged 95.06 over the last ten years. The current PE ratio of 14.69 is 85% below the historical average. Over the past ten years, LGND's PE ratio was at its highest in the Sep 2020 quarter at 794.33, when the stock price was $95.32 and the EPS was $0.12. The lowest value was in the Dec 2019 quarter, when it reached 3.15 with a price of $104.29 and an EPS of $33.13.

Average
95.06
Median
45.74
Minimum
3.15
Maximum
794.33

Ligand Pharmaceuticals PE ratio by year

Maximum annual decrease: -91.22% in 2018

Year PE ratio Change
2023 23.65 N/A
2022 N/A N/A
2021 44.9 N/A
2020 N/A N/A
2019 3.15 -84.28%
2018 20.04 -91.22%
2017 228.22 N/A
2016 N/A N/A
2015 9.34 -89.64%
2014 90.19 -3.98%

LGND average PE ratio chart

What is the average PE ratio of LGND for the past years

The current PE ratio of LGND is below the 3, 5 and 10-year averages.

3-year avg
44.65
5-year avg
90.66
10-year avg
95.06
15-year avg
98.2

LGND PE vs peers

What is LGND's PE ratio compared to its peers

LGND's PE ratio is lower than its peer stocks LLY and MRK, but it is greater than JNJ's and BAX's.

Stock name PE ratio Market cap
BAX Baxter International Inc 6.46 $17.21B
JNJ Johnson & Johnson 9.54 $350.27B
LGND Ligand Pharmaceuticals Inc 14.69 $1.44B
AMGN Amgen Inc 42.42 $160.19B
LLY ELI LILLY & Co 128.8 $834.88B
MRK Merck & Co Inc 142.29 $327.95B
BMY Bristol Myers Squibb Co N/A $83.52B
PFE Pfizer Inc N/A $156B

Frequently asked questions

What is Ligand Pharmaceuticals's PE ratio?

The price to earnings ratio for LGND stock is 14.69 as of Jun 14, 2024.

What is the 3-year average PE ratio for Ligand Pharmaceuticals (LGND)?

The 3-year average PE ratio for LGND stock is 44.65.

What is the 5-year average PE ratio for Ligand Pharmaceuticals (LGND)?

The 5-year average PE ratio for LGND stock is 90.66.

What is the highest PE ratio for LGND?

The highest quarterly PE ratio in the last ten years has been 794.33 and it was in the Sep 2020 quarter.

How does the current PE ratio for LGND compare to its historical average?

LGND's price to earnings ratio is currently 85% below its 10-year historical average.

How is LGND's PE ratio calculated (Ligand Pharmaceuticals PE ratio formula)?

The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Jun 14, 2024), Ligand Pharmaceuticals's stock price is $80.06. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $5.45. Therefore, Ligand Pharmaceuticals's P/E ratio for today is 14.69. PE RATIO(14.69) = STOCK PRICE($80.06) / TTM EPS($5.45)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.